Embody vs Hims & Hers: GLP-1 Prices Compared
Embody and Hims & Hers do not sell the same product here: Embody sells compounded semaglutide injection (flat rate at $49/month) and compounded tirzepatide injection (flat rate at $99/month); Hims & Hers sells Wegovy injection ($238 first month) and Zepbound injection ($338 first month). Both sell semaglutide and tirzepatide, as different products: compounded semaglutide injection at Embody, Wegovy injection at Hims & Hers; compounded tirzepatide injection at Embody, Zepbound injection at Hims & Hers. What each sells here: Embody, compounded GLP-1s only; Hims & Hers, FDA-approved brand-name GLP-1s only. Compounded GLP-1s are not FDA-approved. Prices checked Nov 4, 2026.
Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices
Each seller's lowest price now
What Embody and Hims & Hers each sell
Both sell semaglutide and tirzepatide, as different products: compounded semaglutide injection at Embody, Wegovy injection at Hims & Hers; compounded tirzepatide injection at Embody, Zepbound injection at Hims & Hers.
EmbodyCompounded semaglutide injection
Advertised entry price
flat rate at $49/monthSupply period unverified; excluded from cost ranking.
Checked
Compounded semaglutide via Embody
Embody · Sourced provider quoteflat monthly rate for weekly GLP-1 injections on Embody's homepage, under a "Pre-Black Friday Sale" (save $200 instantly) with no end date; the plan length is not stated; no hidden fees, shipped to your door
Price conditions
flat monthly rate for weekly GLP-1 injections on Embody's homepage, under a "Pre-Black Friday Sale" (save $200 instantly) with no end date; the plan length is not stated; no hidden fees, shipped to your door
Weekly injection. The product pages this price came from on Oct 16, 2026 (a 1-month supply at $79 on sale, or $69 to $76 a month on 3- to 12-month supplies) no longer load, and the homepage shows only this flat rate. Embody's Terms (updated April 24, 2026) state different prices: $99 the first month then $299 a month, or a flat $199 a month. Not available in every state. Compounded; not FDA-approved.
Compounded tirzepatide injection
Advertised entry price
flat rate at $99/monthSupply period unverified; excluded from cost ranking.
Checked
Compounded tirzepatide via Embody
Embody · Sourced provider quoteflat monthly rate for weekly GLP-1 / GIP injections on Embody's homepage, under a "Pre-Black Friday Sale" (save $200 instantly) with no end date; the plan length is not stated; no hidden fees, shipped to your door
Price conditions
flat monthly rate for weekly GLP-1 / GIP injections on Embody's homepage, under a "Pre-Black Friday Sale" (save $200 instantly) with no end date; the plan length is not stated; no hidden fees, shipped to your door
Weekly injection. The product pages this price came from on Oct 16, 2026 (a 1-month supply at $129 on sale, or $119 to $126 a month on 3- to 12-month supplies) no longer load, and the homepage shows only this flat rate. Embody's Terms (updated April 24, 2026) state different prices: $149 the first month then $399 a month, or the flat semaglutide price plus $100 a month. Not available in every state. Compounded; not FDA-approved.
Hims & HersWegovy injection
Advertised entry price
$238 first monthCalculated: $199 medication + $39 introductory membership/provider fee (hims.com). Charges billed separately.
Membership then $149/month, plus medication. (hims.com)
Separate billing cycles; excluded from cost ranking.
Checked
Wegovy pen via Hims
Hims & Hers · Sourced provider quotePrice conditions
Calculated: $199 medication + $39 introductory membership/provider fee
Medication starts at $199 a month if prescribed; Hims states no end date for this price. The separate required membership is $39 for the first month, then automatically renews at $149/month. Maintenance-dose total not verified; availability and eligibility vary.
Membership then $149/month, plus medication.
Zepbound injection
Advertised entry price
$338 first monthCalculated: $299 medication + $39 introductory membership/provider fee (hims.com). Charges billed separately.
Membership then $149/month, plus medication. (hims.com)
Separate billing cycles; excluded from cost ranking.
Checked
Zepbound vial via Hims
Hims & Hers · Sourced provider quotePrice conditions
Calculated: $299 medication + $39 introductory membership/provider fee
Medication starts at $299 a month if prescribed; Hims lists the Zepbound KwikPen from $299 as well. The separate required membership is $39 for the first month, then automatically renews at $149/month. Hims' treatment list also shows Zepbound at $1,899/mo without naming a dose or form. Maintenance-dose total not verified.
Membership then $149/month, plus medication.
Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss
All Embody and Hims & Hers offers
Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.
Search by medication, provider or treatment goal. Examples follow.
4 offers · US self-pay
This order is by the number alone, with no referral input. Partner links may earn us a referral fee.
- Wegovy pen via Hims
Semaglutide · Telehealth (branded)
Advertised price$238 first monthCalculated: $199 medication + $39 introductory membership/provider fee (hims.com). Charges billed separately.
Membership then $149/month, plus medication. (hims.com)
Separate billing cycles; excluded from cost ranking.
Checked
Maintenance priceView offerNo separate dose price verified
Price conditions & source
Medication starts at $199 a month if prescribed; Hims states no end date for this price. The separate required membership is $39 for the first month, then automatically renews at $149/month. Maintenance-dose total not verified; availability and eligibility vary.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source (hims.com) - Zepbound vial via Hims
Tirzepatide · Telehealth (branded)
Advertised price$338 first monthCalculated: $299 medication + $39 introductory membership/provider fee (hims.com). Charges billed separately.
Membership then $149/month, plus medication. (hims.com)
Separate billing cycles; excluded from cost ranking.
Checked
Maintenance priceView offerNo separate dose price verified
Price conditions & source
Medication starts at $299 a month if prescribed; Hims lists the Zepbound KwikPen from $299 as well. The separate required membership is $39 for the first month, then automatically renews at $149/month. Hims' treatment list also shows Zepbound at $1,899/mo without naming a dose or form. Maintenance-dose total not verified.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source (hims.com) - Advertised priceflat rate at $49/month
Supply period unverified; excluded from cost ranking.
Checked
Maintenance priceView offerNo separate dose price verified
Price conditions & source
Advertised price: flat monthly rate for weekly GLP-1 injections on Embody's homepage, under a "Pre-Black Friday Sale" (save $200 instantly) with no end date; the plan length is not stated; no hidden fees, shipped to your door
Weekly injection. The product pages this price came from on Oct 16, 2026 (a 1-month supply at $79 on sale, or $69 to $76 a month on 3- to 12-month supplies) no longer load, and the homepage shows only this flat rate. Embody's Terms (updated April 24, 2026) state different prices: $99 the first month then $299 a month, or a flat $199 a month. Not available in every state. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source (joinem.co) - Advertised priceflat rate at $99/month
Supply period unverified; excluded from cost ranking.
Checked
Maintenance priceView offerNo separate dose price verified
Price conditions & source
Advertised price: flat monthly rate for weekly GLP-1 / GIP injections on Embody's homepage, under a "Pre-Black Friday Sale" (save $200 instantly) with no end date; the plan length is not stated; no hidden fees, shipped to your door
Weekly injection. The product pages this price came from on Oct 16, 2026 (a 1-month supply at $129 on sale, or $119 to $126 a month on 3- to 12-month supplies) no longer load, and the homepage shows only this flat rate. Embody's Terms (updated April 24, 2026) state different prices: $149 the first month then $399 a month, or the flat semaglutide price plus $100 a month. Not available in every state. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source (joinem.co)
Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.
Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.
The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of October 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. The default order of a list is by price, lifted by a referral boost for the sellers that pay us, and says so beside the list; every lowest-cost sort reads the price alone. Every partner is labeled. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. The default order of a list is by price, lifted by a referral boost for the sellers that pay us, and says so beside the list; every lowest-cost sort reads the price alone. Every partner is labeled. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.
Embody vs Hims & Hers: reviews, BBB and FDA
What Trustpilot, the BBB and the FDA say about each. These records do not measure medical quality or results.
Embody
Trustpilot 3.9 from 11,729 reviews. The BBB rates Embody C+, with 315 complaints filed in the last 3 years. It is not BBB accredited. We found no FDA warning letter naming Embody as of Nov 6, 2026.
Is Embody legit?Hims & Hers
Trustpilot 2.9 from 9,723 reviews. The BBB lists Hims & Hers but does not currently rate it. It is BBB accredited. The FDA sent Hims & Hers 2 warning letters (Sep 9, 2025) about claims on its website.
Is Hims & Hers legit?Embody vs Hims & Hers: common questions
Is Embody or Hims & Hers cheaper for GLP-1 medication?
They do not sell the same product here, so neither is cheaper for the same medication. Only Embody: Compounded semaglutide injection flat rate at $49/month; Compounded tirzepatide injection flat rate at $99/month. Only Hims & Hers: Wegovy injection $238 first month ($199 medication + $39 first-month membership/provider fee); Zepbound injection $338 first month ($299 medication + $39 first-month membership/provider fee). Both sell semaglutide and tirzepatide, as different products: compounded semaglutide injection at Embody, Wegovy injection at Hims & Hers; compounded tirzepatide injection at Embody, Zepbound injection at Hims & Hers. A compounded product is not a cheaper version of an FDA-approved brand; it is a different, unapproved product.
Do Embody and Hims & Hers sell FDA-approved GLP-1s or compounded versions?
What each sells here: Embody, compounded GLP-1s only; Hims & Hers, FDA-approved brand-name GLP-1s only. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.
What do Embody and Hims & Hers prices include?
Embody, compounded semaglutide injection: flat rate at $49/month, flat monthly rate for weekly GLP-1 injections on Embody's homepage, under a "Pre-Black Friday Sale" (save $200 instantly) with no end date; the plan length is not stated; no hidden fees, shipped to your door. Embody, compounded tirzepatide injection: flat rate at $99/month, flat monthly rate for weekly GLP-1 / GIP injections on Embody's homepage, under a "Pre-Black Friday Sale" (save $200 instantly) with no end date; the plan length is not stated; no hidden fees, shipped to your door. Hims & Hers, Wegovy injection: $238 first month ($199 medication + $39 first-month membership/provider fee); membership then $149/month, plus medication. Hims & Hers, Zepbound injection: $338 first month ($299 medication + $39 first-month membership/provider fee); membership then $149/month, plus medication.
When were Embody and Hims & Hers prices last checked?
Prices checked Nov 4, 2026. Each quote links the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.
Seller pages re-read automatically : 1 of 2 opened and checked for price changes. How prices stay current